Role of Efhc2 in RA mediated segmentation of pronephros development. a Wild-type embryos or efhc2 morphants were treated with RA. Morphological changes caused by RA treatment in wild-type and efhc2 morphants. WISH showing expression of slc12a1 (DE), slc12a3 (DL) and stc1 (CS). Wild-type embryos or efhc2 morphants were treated with RA (1 × 10−7 M). efhc2 morphants treated with RA show expansion of expression domain of DE marker slc12a1 and almost or complete loss of DL and CS markers slc12a3 and stc1 as compared with wild-type embryos treated with RA. b Summary of the effects of RA on WT and efhc2 morphants at 48 hpf
|